(Q52582128)

English

Strategic therapeutic targeting to overcome venetoclax resistance in aggressive B-cell lymphomas.

scientific article published on 17 April 2018

In more languages
default for all languages
No label defined

No description defined

Statements

Strategic Therapeutic Targeting to Overcome Venetoclax Resistance in Aggressive B-cell Lymphomas (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit